scispace - formally typeset
E

Emma L. Kaplan

Researcher at Novartis

Publications -  5
Citations -  231

Emma L. Kaplan is an academic researcher from Novartis. The author has contributed to research in topics: Pyruvate dehydrogenase kinase & Pyruvate dehydrogenase phosphatase. The author has an hindex of 4, co-authored 5 publications receiving 226 citations.

Papers
More filters
Journal ArticleDOI

Secondary Amides of (R)-3,3,3-Trifluoro-2-hydroxy-2-methylpropionic Acid as Inhibitors of Pyruvate Dehydrogenase Kinase

TL;DR: Methyl substitution of the piperazine at the 2- and 5-positions markedly increased the potency of the lead compound (>1,000-fold) and oral bioavailability of the compounds in this series is good and is optimal when the 4-position of thepiperazine is substituted with an electron-poor benzoyl moiety.
Journal ArticleDOI

Triterpene and diterpene inhibitors of pyruvate dehydrogenase kinase (PDK).

TL;DR: The oxime 12 and dehydroabietyl amine 2 exhibit a blood glucose lowering effect in the diabetic ob/ob mouse after a single oral dose of 100 micromol/kg, however, the mechanism of the blood glucose lowered effect is likely unrelated to PDK inhibition.
Journal ArticleDOI

Triterpene and Diterpene Inhibitors of Pyruvate Dehydrogenase Kinase (PDK).

TL;DR: This article showed that triterpenes with 17-β hydroxyl and abietane derivatives are inhibitors of pyruvate dehydrogenase kinase (PDK) activity.